Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: food  drug  administration  fda  abbott  tecnis  symfony  sight  eyes  treatment  cataracts  multivu  7870151  pixeefox  spiderweb  facelift  plasticsurgery  nonsurgical  procedure  face  lift  istanbul  bulentcihantimur  brain  health  neurological  psychology  neuropsychology  university  pittsburgh  brookdale  multivu  7722157  pet  dog  cute  opening  purina  family  hospital  health  children  multivu  7835951  immortality  neurosurgery  justice  legal  ethics  politics  the  immortal  joseph  walton  alfred  book  trailer  scifi  research  astro  science  cancer  early  stage  breast  cancer  health  technology  advancement  doctors  multivu  7661231  research  astro  science  cancer  early  stage  breast  cancer  health  technology  advancement  doctors  multivu  7661231  research  astro  science  cancer  early  stage  breast  cancer  health  technology  advancement  doctors  multivu  7661231  breast  cancer  cancer  woman  surgeons  treatment  technology  medical  scartm  surgery  health  multivu  7644051  cancer  head  neck  health  ehns  awareness  healthcare  disease  prevention  surgery  multivu  7628151  cardinal  health  healthcare  medical  injury  surgery  supplies  consumer  health  hospital  healing  multivu  7622451  loreal  international  awards  social  responsibility  dermatology  albinism  skin  disease  disorder  health  multivu  7554651 
Search // surgery
Results 13-24 of 96 for ' surgery ' (1 seconds)
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved the Tecnis Symfony® Intraocular Lenses for the treatment of cataracts. The first in a new category of intraocular lenses (IOLs), the Tecnis Symfony lenses are the only lenses in the United States that provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia by helping people focus on near objects. The FDA approval includes a version of the lens for people with astigmatism, the Tecnis Symfony Toric IOL. Cataracts are a common condition, with almost 4 million cataract surgeries performed each year, and that number is expected to increase.1 By age 80, more than half of all Americans either have a cataract or have had cataract surgery.2 However, cataracts do not just impact seniors. In 2016 it is estimated that nearly one in four cataract surgeries will be performed on people younger than 65.1 Many people who have cataracts experience other problems with their vision, such as presbyopia and astigmatism, which the Symfony lenses also address. Presbyopia, which affects most people over age 40, means people have lost the ability to focus on objects up close and often require glasses to perform near visual tasks. Astigmatism is when the cornea is misshapen, which causes blurry or distorted vision. To view the multimedia release go to: http://www.multivu.com/players/English/7870151-abbott-intraocular-lenses/
Categories // Miscellaneous 
Added: 2813 days ago by MultiVuVideos
Runtime: 0m35s | Views: 766 | Comments: 0
Not yet rated
 

 

 

As brain health becomes an ever greater concern for people of all ages, the nation’s largest senior living provider is now guiding its residents on developing and putting into practice personalized brain health plans. Brookdale devised the new resident program with the help of a neuropsychologist specializing in brain health. The company is putting it into place at its independent and assisted living communities across the country. Through the new initiative, Brookdale’s residents will be offered a four-session course that explains key factors in brain health through classroom learning and hands-on activities. Each participant will be guided on creating an individual brain health plan to use on a daily basis. The course was developed with the assistance of Dr. Paul Nussbaum, who is Board Certified in clinical and geropsychology with a specialty in neuropsychology. An adjunct professor of neurological surgery at the University of Pittsburgh, he is the author of “Save Your Brain.” To view the multimedia release go to: http://www.multivu.com/players/English/7722157-brookdale-brain-health/
Categories // Miscellaneous 
Added: 2857 days ago by MultiVuVideos
Runtime: 0m41s | Views: 684 | Comments: 0
Not yet rated
 

 

 

Madison Taliaferro spent weeks in the hospital in 2012. After a decade of suffering from cystic fibrosis, she underwent a double lung transplant. She powered through the difficult surgery and the recovery that followed –long days of physical therapy and rehabilitation. Her parents were there. Her best friend visited from Kansas. Grandparents rotated shifts so she was never alone. But one request still lingered. “I just wanted to see my dogs,” she remembers. Having suffered from the effects of chronic illness for the decade prior, Madison was no stranger to long days at home, isolated from the school germs that could turn her illness into a critical condition with a single sneeze. When her friends couldn’t visit, her dogs were there. But at the hospital, they weren’t. To view the multimedia release go to: http://www.multivu.com/players/English/7835951-purina-family-pet-center-st-louis-childrens/
Categories // Miscellaneous 
Added: 2869 days ago by MultiVuVideos
Runtime: 1m20s | Views: 714 | Comments: 0
Not yet rated
 

 

 

Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated. Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal. “We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.” To view the multimedia release go to: http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Categories // Miscellaneous 
Added: 3075 days ago by MultiVuVideos
Runtime: 1m25s | Views: 816 | Comments: 0
Not yet rated
 

 

 

Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated. Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal. “We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.” To view the multimedia release go to: http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Categories // Miscellaneous 
Added: 3075 days ago by MultiVuVideos
Runtime: 3m4s | Views: 806 | Comments: 0
Not yet rated
 

 

 

Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated. Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal. “We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.” To view the multimedia release go to: http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Categories // Miscellaneous 
Added: 3075 days ago by MultiVuVideos
Runtime: 2m3s | Views: 940 | Comments: 0
Not yet rated
 

 

 

Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, announced today the launch of its Hidden ScarTM Surgery program designed to certify surgeons and establish Centers of Excellence at major cancer centers and hospitals across the country. This innovative program will train surgeons on advanced minimally invasive and minimal access surgical approaches that deliver optimal clinical and aesthetic outcomes for patients. As part of the company’s broader women’s health initiative, Invuity is hosting a Hidden Scar Breast Cancer Surgery training course in advance of the American College of Surgeons (ACS) Clinical Congress. Invuity aims to transform the surgical treatment of breast cancer with this advanced surgical approach for nipple sparing mastectomies and lumpectomies (breast conserving surgery). Hidden Scar Breast Cancer Surgery expands surgical options for patients, offering superior cosmetic outcomes that can improve their psychological and emotional recovery and enhance quality of life after surgery.1 With growing demand for less invasive alternatives to breast cancer surgery, surgeons need to operate through smaller incisions with limited fields of vision. Invuity’s illumination technology allows surgeons to access and visualize the entire breast cavity through discrete incision locations, enabling surgeons to safely and effectively treat breast cancer while preserving the natural shape of the breast and thereby minimizing and hiding the scars. To view the multimedia release go to: http://www.multivu.com/players/English/7644051-invuity-hidden-scar-breast-cancer-surgery-program/
Categories // Miscellaneous 
Added: 3101 days ago by MultiVuVideos
Runtime: 3m30s | Views: 793 | Comments: 1
Not yet rated
 

 

 

The European Head and Neck Society (EHNS) and the Make Sense Campaign, today announced the launch of the Third Annual Head and Neck Cancer Awareness week (21–25 September). Through the pan-European Awareness Week, the EHNS and Make Sense Campaign promote education on head and neck cancer risk factors, disease prevention and disease signs and symptoms for both patients and healthcare professionals. “Each year 350,000 people are diagnosed with head and neck cancer across Europe, and over half will not be alive after five years. However, if diagnosed and treated earlier, patients can have an 80 – 90% survival rate.” said Professor René Leemans, President of the EHNS and Professor and Chief of Otolaryngology – Head and Neck Surgery at VU University Medical Centre. “Through the Make Sense Campaign we are educating people about the early signs of the disease and encouraging them to seek professional help in a timely manner. Additionally, we are advocating for the best possible standards of patient care so that their outcomes can be optimised once they have been diagnosed with the disease.” To view the multimedia release go to: http://www.multivu.com/players/uk/7628151-support-head-neck-cancer-patients/
Categories // Miscellaneous 
Added: 3110 days ago by MultiVuVideos
Runtime: 1m6s | Views: 562 | Comments: 0
Not yet rated
 

 

 

Cardinal Health, which provides medical products and services to many of America’s most prestigious medical institutions, today announced the launch of the Hospital Quality at Home™ brand, a new line of hospital-quality products available over the counter to help loved ones and caregivers transition care from the hospital to home. The product line provides a full assortment of hospital-quality products for consumers categorized as Advanced Wound Care, First Aid, Personal Care, and Home Healthcare which help provide comfort and independence, while helping to promote healing. When leaving the hospital after childbirth, injury or surgery, the care you provide for yourself or a loved one is important. Each year, hospitals discharge 35.1 million patients1 with 65 percent of those discharged to the home setting for care.2 Effective post-hospital care is critical to avoid re-admission as one in five patients are readmitted within 30 days of discharge.2 With rising health care costs3 the Hospital Quality at Home™ line of products can provide patients, loved ones, and caregivers effective and cost-efficient ways to manage care at home. To view the multimedia release go to: http://www.multivu.com/players/English/7622451-cardinal-health-hospital-quality-at-home/
Categories // Miscellaneous 
Added: 3117 days ago by MultiVuVideos
Runtime: 0m30s | Views: 702 | Comments: 0
Not yet rated
 

 

 

L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada. For Latin America Dr. Gioconda Gaudiano from Republic of Panama Moon Children - Providing mobile surgery clinics to Indigenous people This initiative provides free consultations, medical treatment and sun education via mobile surgery clinics to the 40,000 indigenous people from the Archipelago of San Blas, a region with the highest incidence of albinism in the world. Albinos can face severe skin problems, such as skin cancer, caused by UV light and sun exposure due to the lack of melanin in their skin. The mobile surgery clinics are able to travel to the Archipelago of San Blas, a community that often shuns medical treatment and avoids protective measures against skin cancer. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
Categories // People and Blog 
Added: 3193 days ago by MultiVuVideos
Runtime: 4m12s | Views: 905 | Comments: 0
Not yet rated
 

 

 

The American Society for Aesthetic Plastic Surgery (ASAPS), is hosting a panel discussion today on the fast-evolving practice of fat grafting, and how surgeons are discovering best practices to produce the most natural looking results. Physician members of ASAPS concur that less is more when it comes to utilizing a patient’s own fat to enhance certain anatomical regions including the breast and buttocks. Further, they agree that fat grafting is proving to be a novel technique for body sculpting previously neglected areas including women’s and men’s shoulders, pectorals, legs and stomachs to create definition. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310752-asaps-plastic-surgery-fat-grafting/
Categories // People and Blog 
Added: 3237 days ago by MultiVuVideos
Runtime: 0m43s | Views: 737 | Comments: 1
Not yet rated
 

 

 

The American Society for Aesthetic Plastic Surgery (ASAPS), is hosting a panel discussion about the latest best practices and uses for injectables including the newest FDA-approved options at The Aesthetic Meeting today in Montreal, Quebec Canada. The panel discussed the latest advances, including the ways various dermal fillers can be utilized to produce optimal results for targeted areas. There are thirteen FDA-approved dermal fillers on the market to-date, providing aesthetic plastic surgeons with the ability to customize anti-aging treatments to patients’ needs. “The filler choices are dictated by a patient’s unique aging pattern, the anatomical area to be treated and physiochemical properties,” explains ASAPS member, Dr. Z. Paul Lorenc. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310753-asaps-facial-rejuvenation-injectables/
Categories // People and Blog 
Added: 3237 days ago by MultiVuVideos
Runtime: 0m28s | Views: 630 | Comments: 1
Not yet rated
 

 

 

Page 2 of 8  |  Go to page     |  ««FIRST «Previous  Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.